middle.news
Microba Doubles Q2 Revenue as MetaXplore Sales Surge in Australia and UK
8:55am on Wednesday 29th of January, 2025 AEDT
•
Healthcare
Read Story
Microba Doubles Q2 Revenue as MetaXplore Sales Surge in Australia and UK
8:55am on Wednesday 29th of January, 2025 AEDT
Key Points
Q2 FY25 revenue surged 102% year-on-year to $4.43 million
MetaXplore test sales in Australia grew 195% versus prior year
UK Early Access Program for MetaXplore shows referral rates matching Australia
Therapeutic programs advancing, including MAP 315 moving toward Phase 2 trial
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Microba Life Sciences (ASX:MAP)
OPEN ARTICLE